SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing intense social media activity as users debate a settlement involving company legal claims, while also reacting to the President's public appearances and ongoing geopolitical developments in the Middle East. Community sentiment remains deeply polarized, with active discussions centering on political alignments, the company's valuation, and speculative theories regarding its future business strategies.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors anticipate the final overall survival event of the REGAL phase 3 clinical trial, with community discussion focused on a potential buyout and the CEO's upcoming appearance on national news. The conversation is heavily driven by speculation regarding the trial's success, high short interest, and the significant implications of a positive data readout for the company's valuation.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors focus on the company's upcoming first-quarter earnings report and the critical U.S. Supreme Court oral arguments scheduled for late April. The community remains deeply divided, with discussions ranging from intense scrutiny of executive compensation and governance to speculative optimism regarding potential pipeline catalysts and strategic acquisition scenarios.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing intense selling pressure and high short interest, driven by concerns over management's capital allocation and broader sector-wide weakness in AI infrastructure stocks. Despite the recent sharp decline, the community is debating whether the stock is nearing a critical bottom or if execution-related catalysts, such as the imminent Microsoft data center handover, are necessary to trigger a reversal.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending as investors weigh strong earnings and raised guidance against a sharp post-earnings sell-off driven by concerns over organic revenue growth and high valuation multiples. The community is actively debating whether the stock's massive rally and premium price tag are fully justified by AI-driven cybersecurity demand or if the stock is poised for a technical correction.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh strong fundamental growth and expanded shipping capacity against ongoing geopolitical volatility in the Strait of Hormuz. The community is focused on the stock's potential for a valuation re-rating as the company scales production, despite short-term fluctuations driven by Middle East energy supply disruptions.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt is experiencing heightened attention as investors weigh institutional accumulation from board members and major funds against the company's Q1 earnings results and ongoing operational restructuring. Community discourse is currently split between optimism regarding the potential of the DTR acquisition and new B2B stablecoin infrastructure versus frustration over persistent stock price volatility and the lack of immediate, high-impact news catalysts.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is seeing increased investor attention driven by its recent TSX uplisting and growing momentum in its paraffinic crude upgrading vertical, which has led to significant insider buying. The community remains focused on the company's ability to successfully scale its Hydrochemolytic technology, balancing long-term optimism over potential industrial partnerships against debates regarding the company's commercial execution and valuation.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is experiencing extreme volatility as investors navigate a combination of broader sector weakness, persistent short-selling pressure, and shifting macro-economic expectations. While community sentiment remains polarized between long-term holders bullish on fundamental silver shortages and frustrated traders reacting to aggressive daily price swings, discussions are heavily focused on the disconnect between the stock's valuation and the company's production growth guidance.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors digest the recent elimination of all convertible notes, a move many in the community view as a critical step toward cleaning up the balance sheet and improving financial flexibility. Discussion is heavily focused on the stock's long-term valuation potential and whether this debt reduction, combined with the upcoming Phase 3 trial for XP-8121, makes the company an increasingly attractive buyout target.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
